Ind Swift Board to consider allotment of warrants convertible into equity shares
Ind Swift Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on November 30, 2004 to consider and approve:1. Allotment of 8,50,000 Warrants to the "Promoters" of the Company convertible into equity shares at any time within 18 months.2. Allotment of 6,50,000 Warrants to the Bodies Corporate convertible into equity shares at any time within 18 months. Ind Swift members approves issue of warrants convertible into Equity Shares on preferential basis
Ind Swift Ltd has informed BSE that the members of the Company in their Extra ordinary General Meeting held on November 16, 2004 have approved the issue of 15,00,000 warrants convertible into Equity Shares on preferential basis to the promoters and outside bodies corporate. Ind Swift launches Novel Drug Delivery of Nitazoxanide
Ind Swift Ltd has informed BSE that it has launched the Novel Drug Delivery (NDDS) of Nitazoxanide an Anti-Diaroheal drug in India. The drug has been launched in the Dispersible tablet form which is suitable for all age groups. Company is second globally to launch the NDDS of this drug after the Innovator.The dispersible tablet containing 200 mg of Nitazoxanide has actually been launched for the treatment of various parasitic infections especially... Ind Swift Board approves preferential issue
Ind Swift Ltd has informed BSE that the Board of Directors in their meeting held on October 16, 2004 have approved the further issue of 15,00,000 warrants convertible into equity shares on preferential basis to promoters and outside bodies corporate.The above issue is subject to members' approval on November 16, 2004 and other necessary approvals.